Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials, Journal of Clinical Oncology, vol.23, issue.34, pp.8664-70, 2005. ,
DOI : 10.1200/JCO.2005.01.6071
Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis, JNCI Journal of the National Cancer Institute, vol.105, issue.21 ,
DOI : 10.1093/jnci/djt270
Progression-free survival as a ,
Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis, JNCI Journal of the National Cancer Institute, vol.105, issue.21, pp.1667-70, 2013. ,
DOI : 10.1093/jnci/djt269
Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Annals of surgery, pp.774-87, 2010. ,